Publications by authors named "Sarath Kumar Murugan"
Article Synopsis
- A new generation of risk calculators (RCs) for detecting clinically significant prostate cancer (csPCa) has been introduced, utilizing MRI data, but their external validation and clinical benefits compared to traditional methods remain uncertain.
- In a study involving 532 men aged 45-74, MRI-based RCs demonstrated better discriminative ability (AUC 0.81-0.87) for csPCa compared to traditional RCs (AUC 0.76-0.80), yet their accuracy varied significantly across different models.
- Although one MRI RC showed clinical usefulness at a specific probability threshold, the Stockholm3 test offered comparable performance but tended to underpredict actual risk.
